Chief Financial Officer
Mr. Finio assumed the role of Chief Financial Officer in November 2020, bringing with him more
than 29 years of financial management experience. He began his career in public accounting at
KPMG LLP before spending nearly 14 years in a variety of financial roles of increasing
responsibility at AstraZeneca. After leaving AstraZeneca, he led finance departments at other
pharmaceutical companies including as VP Finance, Daiichi Sankyo Pharma Development, Chief
Financial Officer, West-Ward Pharmaceuticals, SVP Finance, Heritage Pharmaceuticals, Chief
Financial Officer, Virtus Pharmaceuticals and, most recently, Chief Financial Officer of
Teligent, Inc., a publicly traded manufacturer and distributor of topical pharmaceutical
products in the United States and injectable pharmaceutical products in Canada, from February
2018 until October 2020.
Mr. Finio holds a Bachelor of Science in Accounting from The Pennsylvania State University, a
Master’s in Business Administration from the University of Delaware, and is an (inactive)
Certified Public Accountant and (inactive) Certified Treasury Professional.